Regorafenib-induced transverse myelopathy after stereotactic body radiation therapy

Journal of Gastrointestinal Oncology

Sharad Goyal²  Michael Nissenblatt¹  Sibo Tian² 

[1] Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey & Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USADepartment of Radiation Oncology, Rutgers Cancer Institute of New Jersey & Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USADepartment of Radiation Oncology, Rutgers Cancer Institute of New Jersey & Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA

关键词: Regorafenib;    stereotactic body radiation therapy (SBRT);    myelopathy;    neurotoxicity;   

DOI  :  10.3978/j.issn.2078-6891.2014.088

学科分类：肿瘤学

来源: Pioneer Bioscience Publishing Company

【 授权许可】

Unknown